Teva Receives US FDA Approval for Generic Version of Epipen Auto-Injector
Teva Receives US FDA Approval for Generic Version of Epipen Auto-Injector
Shots:
- Teva’s EpiPen and EpiPen Jr (epinephrine) auto-injector will be used to treat allergic reaction including anaphylaxis in adults and pediatric patients weighing >33 pounds
- The US FDA approval is prompted to lower cost along with safety and effectiveness for patients
- EpiPen will be marketed in 0.3 mg and 0.15 mg doses